An in-depth study examining approaches to spreading and adopting innovation in the health sector has been published by the AHSN Network to help AHSNs, and partners, understand and harness the AHSN collective experience and expertise.

The review, which identifies the different approaches used across the 15 AHSNs within the Network, highlights the complexity of spread work; the diversity of approaches; the influential factors; and provides recommendations for the future.

This research provides the first aggregated view of approaches and challenges to spread and adoption across the AHSN Network, to help the AHSNs and our partners understand the complexity and variation. As well as mapping approaches across the AHSN Network, the review included a deep dive into the Transfers of Care Around Medicines (TCAM) national programme.

Professor Gary Ford, Chair of the AHSN Network and Chief Executive of Oxford AHSN said: “This review expands our knowledge base and will increase our capability to spread innovation in the NHS.

“Since our formation in 2013, the AHSNs have amassed significant expertise in the approaches and challenges to adoption and spread of innovation. The findings of this review highlight the considerations AHSNs take to their individual approach to adoption and spread and provides us with an overview, which will enable us to reflect and learn.

“The review highlights a number of factors to consider and different types of approaches, which will be of use to those in local and national systems trying to spread innovation.”

The review was commissioned and funded by the AHSN Network and the NHS England Innovation, Research and Life Sciences (IRLS) team. The research was undertaken by three study partners Wessex AHSN; South West AHSN; Centre for Healthcare Innovation Research (CHIR) at City, University of London.

All 15 AHSNs participated in the study, which took place from January to November 2020, studying spread and adoption activity between January 2018 and January 2020. 143 interviews were conducted with AHSN staff to identify approaches applied by each AHSN to local/regional and national spread programmes.

A synthesis of findings was used to develop conclusions and recommendations about spread and adoption for the AHSN Network.

Major findings from the review were:

  • A range of high-level and project level approaches to adoption and spread were identified and described in the report.
  • There was no single methodology or ‘one best way’ to do adoption and spread, reflecting the inherent complexity of adoption and spread work, and diversity of activities within AHSNs.
  • Flexibility with approaches is paramount due to the dynamic and multifaceted nature of health systems.
  • Despite some innovations being intrinsically ‘simple’; the contexts, people, and pathways they touch are usually complex, therefore adoption and spread are complex.
  • AHSNs reported success using whole-system and relationship/engagement-focused approaches, engaging existing networks and building new networks across sectors and organisations.
  • To spread innovation, it’s important to think ‘system’ and engage widely. This increases ownership within adoption sites from the start and supports sustainability.

The research highlights the depth of spread and adoption experience and expertise across the AHSN Network. The report concludes with 24 recommendations which the AHSNs and wider health system can learn and benefit from, increasing our capability to successfully spread innovation.

Read a summary of the report, including additional recommendations for the health and care system based on the findings.

Read the full report.

  • Polypharmacy Action Learning Set celebrates 1000th delegate

    Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]

  • Meet the innovator: Jo Barosa, Qbtech

    Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]

  • Prevention may be the cure, but innovation the best course of treatment

    Dr Cheryl Crocker, interim Chief Operating Officer at the Health Innovation Network, explains the vital role innovation plays to not only reduce waiting lists and improve access to care, but to decrease system pressure by improving people’s health and keeping them well for longer.  The new Government has rightly declared its focus on moving the [...]